Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Dengue

Drug Information

Target Indication

Dengue

Clinical Trial

Last updated: 2/10/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Related Pipeline

Influenza (Healthy Volunteers)

Type 2 Diabetes Mellitus

Diphtheria

Non Small Cell Lung Cancer

Influenza